FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment

The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in detecting viable tumours in patients with metastasised non-seminomatous testicular cancer and residual and new masses post chemotherapy remains to be determined. We describe the case of a 41-year-ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Quak, Elske, Kovacs, Iringo, Oyen, Wim J. G., van der Graaf, Winette T. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532687/
https://www.ncbi.nlm.nih.gov/pubmed/26279698
http://dx.doi.org/10.1007/s13139-015-0321-9
_version_ 1782385236938588160
author Quak, Elske
Kovacs, Iringo
Oyen, Wim J. G.
van der Graaf, Winette T. A.
author_facet Quak, Elske
Kovacs, Iringo
Oyen, Wim J. G.
van der Graaf, Winette T. A.
author_sort Quak, Elske
collection PubMed
description The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in detecting viable tumours in patients with metastasised non-seminomatous testicular cancer and residual and new masses post chemotherapy remains to be determined. We describe the case of a 41-year-old patient with metastasised non-seminomatous testicular cancer, with both retroperitoneal and extra-retroperitoneal residual masses post chemotherapy, for whom FDG-PET/CT guided major treatment decisions. FDG-PET/CT correctly identified the locations of viable tumour, as was proved by histology, and successfully guided surgery. In conclusion, in selected cases surveillance of patients with non-seminomatous testicular cancer with FDG-PET/CT can guide major treatment decisions when considering surgery for metastatic disease.
format Online
Article
Text
id pubmed-4532687
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-45326872015-08-15 FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment Quak, Elske Kovacs, Iringo Oyen, Wim J. G. van der Graaf, Winette T. A. Nucl Med Mol Imaging Case Report The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in detecting viable tumours in patients with metastasised non-seminomatous testicular cancer and residual and new masses post chemotherapy remains to be determined. We describe the case of a 41-year-old patient with metastasised non-seminomatous testicular cancer, with both retroperitoneal and extra-retroperitoneal residual masses post chemotherapy, for whom FDG-PET/CT guided major treatment decisions. FDG-PET/CT correctly identified the locations of viable tumour, as was proved by histology, and successfully guided surgery. In conclusion, in selected cases surveillance of patients with non-seminomatous testicular cancer with FDG-PET/CT can guide major treatment decisions when considering surgery for metastatic disease. Springer Berlin Heidelberg 2015-02-13 2015-09 /pmc/articles/PMC4532687/ /pubmed/26279698 http://dx.doi.org/10.1007/s13139-015-0321-9 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Case Report
Quak, Elske
Kovacs, Iringo
Oyen, Wim J. G.
van der Graaf, Winette T. A.
FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
title FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
title_full FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
title_fullStr FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
title_full_unstemmed FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
title_short FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
title_sort fdg-pet/ct in a patient with poor-risk non-seminoma testis with mature teratoma and secondary gliosarcoma: multimodality imaging for guiding multimodality treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532687/
https://www.ncbi.nlm.nih.gov/pubmed/26279698
http://dx.doi.org/10.1007/s13139-015-0321-9
work_keys_str_mv AT quakelske fdgpetctinapatientwithpoorrisknonseminomatestiswithmatureteratomaandsecondarygliosarcomamultimodalityimagingforguidingmultimodalitytreatment
AT kovacsiringo fdgpetctinapatientwithpoorrisknonseminomatestiswithmatureteratomaandsecondarygliosarcomamultimodalityimagingforguidingmultimodalitytreatment
AT oyenwimjg fdgpetctinapatientwithpoorrisknonseminomatestiswithmatureteratomaandsecondarygliosarcomamultimodalityimagingforguidingmultimodalitytreatment
AT vandergraafwinetteta fdgpetctinapatientwithpoorrisknonseminomatestiswithmatureteratomaandsecondarygliosarcomamultimodalityimagingforguidingmultimodalitytreatment

Ejemplares similares